HKD 6.25
(0.32%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -114.6 Million CNY | -427.85% |
2022 | -21.71 Million CNY | 45.44% |
2021 | -39.8 Million CNY | 67.19% |
2020 | -121.26 Million CNY | -51.8% |
2019 | -79.88 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -32.98 Million CNY | 0.0% |
2024 Q1 | -32.98 Million CNY | 49.35% |
2023 Q3 | -65.11 Million CNY | -101.04% |
2023 FY | - CNY | -427.85% |
2023 Q2 | -32.39 Million CNY | 0.0% |
2023 Q1 | -32.39 Million CNY | 3.35% |
2023 Q4 | -65.11 Million CNY | 0.0% |
2022 Q2 | -21.58 Million CNY | 0.0% |
2022 Q1 | -21.58 Million CNY | -57.91% |
2022 FY | - CNY | 45.44% |
2022 Q4 | -33.51 Million CNY | 0.0% |
2022 Q3 | -33.51 Million CNY | -55.27% |
2021 Q2 | -12.47 Million CNY | 0.0% |
2021 Q4 | -13.66 Million CNY | 0.0% |
2021 Q3 | -13.66 Million CNY | -9.58% |
2021 Q1 | -12.47 Million CNY | 0.0% |
2021 FY | - CNY | 67.19% |
2020 FY | - CNY | -51.8% |
2019 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Vincent Medical Holdings Limited | 104.43 Million HKD | 209.737% |